Quick Summary
Substance use during pregnancy affects both mother and developing baby, and stopping safely usually requires professional medical care. NIDA estimates about 5% of pregnant women use one or more addictive substances, yet fear of stigma keeps many from seeking help.
Key Takeaways
- Substance use during pregnancy affects both the mother and the developing fetus.
- NIDA estimates about 5% of pregnant women use one or more addictive substances.
- Stopping safely typically requires professional medical intervention.
- Fear of stigma, legal consequences, or losing custody keeps many from seeking care.
- Compassionate, trauma-informed treatment supports the health of mother and baby.
The Statistics: Prevalence and Impact
The impact of substance use during pregnancy extends across all demographics. Clinical data from the National Institutes of Health (NIH) highlights the severity of the issue. Approximately 5% of pregnant women use one or more addictive substances. Smoking tobacco or marijuana, taking prescription pain relievers, or using illegal drugs during pregnancy is associated with double or even triple the risk of stillbirth. Children born to mothers who drank and smoked beyond the first trimester have a twelvefold increased risk for sudden infant death syndrome (SIDS). These statistics underscore that substance use during pregnancy is not a personal failing, it is a medical emergency that demands compassionate, professional intervention.How Substances Affect the Developing Fetus
Many substances pass easily through the placenta, meaning that the drugs a pregnant woman takes directly reach the fetus. Because the fetal liver and organs are not fully developed, they cannot process these chemicals, leading to prolonged exposure and severe developmental consequences. The following table outlines the primary risks associated with the most commonly misused substances during pregnancy.| Substance | Primary Risks to the Fetus | Long-Term Consequences |
| Alcohol | Fetal Alcohol Spectrum Disorders (FASD), physical deformities, low birth weight. | Cognitive deficits, behavioral issues, lifelong learning disabilities. |
| Opioids (Heroin, Prescription Pills) | Neonatal Abstinence Syndrome (NAS), premature birth, stunted growth. | Neurodevelopmental delays, severe withdrawal symptoms at birth. |
| Stimulants (Cocaine, Methamphetamine) | Placental abruption, severe maternal hypertension, premature delivery. | Cognitive impairments, attention deficits, emotional dysregulation. |
| Marijuana (Cannabis) | Low birth weight, increased risk of stillbirth (2.3x greater risk). | Potential long-term impacts on executive functioning and attention. |
Understanding Neonatal Abstinence Syndrome (NAS)
Neonatal Abstinence Syndrome (NAS) occurs when a baby goes through physical withdrawal upon birth due to chronic in utero exposure to addictive substances. While most commonly associated with maternal opioid use, NAS can also result from exposure to benzodiazepines, alcohol, and barbiturates. The incidence of NAS has continued to rise in recent years, highlighting the urgent need for maternal treatment. Symptoms of NAS can develop immediately or up to 14 days after birth and often include excessive or high-pitched crying, fever, hyperactive reflexes, irritability, poor feeding, rapid breathing, seizures, sleep problems, slow weight gain, and trembling. Managing NAS requires specialized neonatal intensive care, emphasizing the critical need for maternal treatment prior to delivery. Approximately 13% of all cases reported to child welfare services are related to neonatal substance exposure, underscoring the far-reaching social consequences of untreated maternal addiction.Barriers to Seeking Treatment During Pregnancy
Despite the known risks, many pregnant women with substance use disorders do not receive the care they need. The barriers to treatment are complex and deeply rooted in systemic issues and societal stigma.- Fear of Legal Consequences: Many women fear that seeking help will result in child welfare involvement or criminal charges, when in reality, seeking treatment demonstrates a commitment to their child’s wellbeing.
- Stigma and Shame: The intense societal judgment surrounding maternal substance use often drives women into isolation, away from the help they desperately need.
- Lack of Specialized Care: Not all treatment centers are equipped to handle the complex medical needs of pregnant women, particularly regarding safe detoxification protocols and fetal monitoring.
Safe and Effective Treatment at Discovery Point Retreat
Treating substance use during pregnancy requires a highly specialized, multidisciplinary approach. Sudden withdrawal from certain substances, particularly opioids and alcohol, can cause severe distress to the fetus, including miscarriage or premature labor. Therefore, medical supervision is absolutely essential. Attempting to detox at home during pregnancy is never safe.Medication-Assisted Treatment (MAT)
For pregnant women struggling with opioid use disorder, Medication-Assisted Treatment (MAT) using buprenorphine or methadone is considered the standard of care by the NIH and SAMHSA. MAT stabilizes the mother’s brain chemistry, prevents severe withdrawal, and significantly reduces the risk of fetal distress and overdose. Clinical research has confirmed that MAT during pregnancy is associated with shorter hospital stays for infants and reduced severity of NAS compared to untreated maternal opioid use. MAT provides a stable intrauterine environment, which is crucial for fetal development.Comprehensive Dual Diagnosis Care
At Discovery Point Retreat, we provide integrated dual diagnosis treatment that addresses both the addiction and any co-occurring mental health conditions, such as depression, anxiety, or trauma. Our trauma-informed care model ensures that expectant mothers receive the emotional support, behavioral therapy (including CBT and DBT), and medical oversight necessary to build a foundation for long-term recovery and healthy motherhood. We treat the whole person, not just the addiction.Frequently Asked Questions
Is it safe to quit drugs or alcohol cold turkey while pregnant?
No. Quitting substances “cold turkey” during pregnancy, especially opioids, alcohol, or benzodiazepines, can cause severe withdrawal symptoms that may lead to fetal distress, premature labor, or miscarriage. Medical supervision is required to ensure the safety of both the mother and the baby. Never attempt to detox at home during pregnancy.Will seeking treatment mean I lose my baby?
Seeking professional medical treatment is the best way to demonstrate a commitment to your health and the health of your child. Healthcare providers and treatment centers prioritize getting mothers the help they need. Proactively seeking care is viewed favorably and is far safer for both mother and baby than continuing untreated substance use.Can Medication-Assisted Treatment (MAT) harm the fetus?
MAT with buprenorphine or methadone is the recommended standard of care for pregnant women with opioid use disorder, as endorsed by the NIH and SAMHSA. While the baby may still experience mild withdrawal (NAS) after birth, MAT prevents the dangerous cycles of intoxication and withdrawal that pose a much higher risk of stillbirth and developmental harm.What is Neonatal Abstinence Syndrome (NAS)?
NAS is a group of conditions caused when a baby withdraws from certain drugs they were exposed to in the womb before birth. It is most commonly associated with opioid exposure but can also result from alcohol, benzodiazepines, and other substances. NAS is treatable in a medical setting, and infants can recover with proper neonatal care. If you or a loved one is struggling with substance use during pregnancy, compassionate medical help is available. You do not have to face this alone. Call Discovery Point Retreat at (855) 245-7133 or visit discoverypointretreat.com/contact-us/ to speak with an admissions specialist today.References
[1] National Institute on Drug Abuse (NIDA), Substance Use While Pregnant and Breastfeeding: https://nida.nih.gov/publications/research-reports/substance-use-in-women/substance-use-while-pregnant-breastfeeding [2] NCBI / StatPearls, Neonatal Abstinence Syndrome: https://www.ncbi.nlm.nih.gov/books/NBK551498/[3] Pediatrics (American Academy of Pediatrics). Marijuana Use During Pregnancy and Breastfeeding: Implications for Neonatal and Childhood Outcomes.We Accept Most Insurance
We’re here to make treatment as accessible and affordable as possible — and are in network with many insurance providers. Not sure about your coverage? We can help.
Sources
- National Institute on Drug Abuse (NIDA), Substance Use While Pregnant and Breastfeeding
- National Institute on Drug Abuse (NIDA), Pregnancy and Early Childhood
Crisis and Support Resources
- 988 Suicide and Crisis Lifeline. Call or text 988, or chat at 988lifeline.org. Free, confidential support 24/7.
- SAMHSA National Helpline. Call 1-800-662-HELP (4357) or visit the SAMHSA National Helpline page for free, confidential referrals to local treatment.
- 911. For any medical emergency, call 911 immediately.
This article is general education and is not medical advice.
